Cargando…

Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis

The kidney renal clear cell carcinoma (KIRC) with poor prognosis is the main histological subtype of the renal cell carcinoma, accounting for 80–90% of patients. Currently, the N6-methyladenosine (m6A) epitranscriptional modification draws much attention. The m6A RNA modification, the most plentiful...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qian, Zhang, Hao, Chen, Quanbing, Wan, Zhenghua, Gao, Xiaoyong, Qian, Wenhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954481/ https://www.ncbi.nlm.nih.gov/pubmed/31976022 http://dx.doi.org/10.1155/2019/5648783

Ejemplares similares

Analysis of METTL3 and METTL14 in hepatocellular carcinoma
por: Liu, Xiangxiang, et al.
Publicado: (2020)

METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021)

Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis
por: Zhang, Ning, et al.
Publicado: (2020)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Identification of Hub Genes Associated With Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis
por: Huang, Hao, et al.
Publicado: (2021)

Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma—a bioinformatics analysis
por: Zhao, Ya-Wei, et al.
Publicado: (2022)

METTL14-mediated N(6)-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma
por: Liu, Zhuonan, et al.
Publicado: (2022)

METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination
por: Shen, Danyang, et al.
Publicado: (2021)

Roles of the m6A methyltransferases METTL3, METTL14, and WTAP in pulmonary tuberculosis
por: Zhang, Tian-Ping, et al.
Publicado: (2022)

Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma
por: Luo, Ting, et al.
Publicado: (2018)

The Distinct Function and Localization of METTL3/METTL14 and METTL16 Enzymes in Cardiomyocytes
por: Arcidiacono, Orazio Angelo, et al.
Publicado: (2020)

Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics
por: Wu, Hongrong, et al.
Publicado: (2021)

Bioinformatics Analysis of the Prognostic and Biological Significance of ZDHHC-Protein Acyltransferases in Kidney Renal Clear Cell Carcinoma
por: Liu, Zhuang, et al.
Publicado: (2020)

Bioinformatics analysis reveals biomarkers with cancer stem cell characteristics in kidney renal clear cell carcinoma
por: Zhang, Zan, et al.
Publicado: (2021)

Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma
por: Cui, Hao, et al.
Publicado: (2020)

Identification and Verification of Biomarker in Clear Cell Renal Cell Carcinoma via Bioinformatics and Neural Network Model
por: Liu, Bin, et al.
Publicado: (2020)

Identification of significant genes with prognostic influence in clear cell renal cell carcinoma via bioinformatics analysis
por: Zhang, Fangyuan, et al.
Publicado: (2020)

Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis
por: Li, Ding, et al.
Publicado: (2022)

Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma
por: Xia, Qi-Dong, et al.
Publicado: (2023)

Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma
por: Wang, Jinxing, et al.
Publicado: (2018)

Identification of genes and pathways involved in kidney renal clear cell carcinoma
por: Yang, William, et al.
Publicado: (2014)

PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis
por: Luo, Yongwen, et al.
Publicado: (2019)

Identification of prognostic genes in kidney renal clear cell carcinoma by RNA-seq data analysis
por: Gu, Yanqin, et al.
Publicado: (2017)

Screening of possible biomarkers and therapeutic targets in kidney renal clear cell carcinoma: Evidence from bioinformatic analysis
por: Peng, Longfei, et al.
Publicado: (2022)

Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
por: Xu, Yeqiu, et al.
Publicado: (2023)

Effect of Bariatric Surgery on Semen Parameters: A Systematic Review and Meta-Analysis
por: Wei, Yong, et al.
Publicado: (2018)

Functions, mechanisms, and therapeutic implications of METTL14 in human cancer
por: Guan, Qian, et al.
Publicado: (2022)

Identification of biological targets of therapeutic intervention for clear cell renal cell carcinoma based on bioinformatics approach
por: Chen, Yongsheng, et al.
Publicado: (2016)

Correction: Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
por: Xu, Yeqiu, et al.
Publicado: (2023)

Insights into roles of METTL14 in tumors
por: Liu, Xin, et al.
Publicado: (2021)

Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma
por: Cui, Hao, et al.
Publicado: (2020)

Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis
por: Xu, Yingying, et al.
Publicado: (2021)

The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer
por: Ge, Yiling, et al.
Publicado: (2023)

Bioinformatics analysis of immune-related prognostic genes and immunotherapy in renal clear cell carcinoma
por: Pan, Ziwen, et al.
Publicado: (2022)

Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
por: Meng, Tong, et al.
Publicado: (2019)

Identification of prognosis‐related alternative splicing events in kidney renal clear cell carcinoma
por: Zuo, Yongdi, et al.
Publicado: (2019)

Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma
por: Wu, Xiaobin, et al.
Publicado: (2022)

Identification of Pathologic Grading-Related Genes Associated with Kidney Renal Clear Cell Carcinoma
por: Xiong, Weijian, et al.
Publicado: (2022)

Identification of anoikis-related subtypes and immune landscape in kidney renal clear cell carcinoma
por: Ding, Wencong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_68ffr9nsa1ocrnlqnqu1tk5g0t